These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 33588783)
1. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI. Auer TA; Walter-Rittel T; Geisel D; Schöning W; Schmelzle M; Müller T; Sinn B; Denecke T; Hamm B; Fehrenbach U BMC Med Imaging; 2021 Feb; 21(1):28. PubMed ID: 33588783 [TBL] [Abstract][Full Text] [Related]
2. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia. Vanhooymissen IJSML; Thomeer MG; Braun LMM; Gest B; van Koeverden S; Willemssen FE; Hunink M; De Man RA; Ijzermans JN; Dwarkasing RS J Magn Reson Imaging; 2019 Mar; 49(3):700-710. PubMed ID: 30252977 [TBL] [Abstract][Full Text] [Related]
3. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions. Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma. Bilreiro C; Soler JC; Ayuso JR; Caseiro-Alves F; Ayuso C Radiol Med; 2021 Nov; 126(11):1379-1387. PubMed ID: 34287759 [TBL] [Abstract][Full Text] [Related]
5. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules. Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242 [TBL] [Abstract][Full Text] [Related]
6. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation? Auer TA; Fehrenbach U; Grieser C; Penzkofer T; Geisel D; Schmelzle M; Müller T; Bläker H; Seehofer D; Denecke T Eur Radiol; 2020 Jun; 30(6):3497-3506. PubMed ID: 32086574 [TBL] [Abstract][Full Text] [Related]
7. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? Roux M; Pigneur F; Baranes L; Calderaro J; Chiaradia M; Decaens T; Kastahian S; Charles-Nelson A; Tselikas L; Costentin C; Laurent A; Azoulay D; Mallat A; Rahmouni A; Luciani A Abdom Radiol (NY); 2018 Jul; 43(7):1670-1681. PubMed ID: 29110059 [TBL] [Abstract][Full Text] [Related]
8. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia. Cannella R; Rangaswamy B; Minervini MI; Borhani AA; Tsung A; Furlan A AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050 [TBL] [Abstract][Full Text] [Related]
9. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy. Sciarra A; Schmidt S; Pellegrinelli A; Maggioni M; Dondossola D; Pasquier J; Cigala C; Tosi D; Halkic N; Bulfamante G; Viale G; Bosari S; Balabaud C; Bioulac-Sage P; Sempoux C Liver Int; 2019 Jan; 39(1):158-167. PubMed ID: 30218633 [TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis. Suh CH; Kim KW; Kim GY; Shin YM; Kim PN; Park SH Eur Radiol; 2015 Apr; 25(4):950-60. PubMed ID: 25537979 [TBL] [Abstract][Full Text] [Related]
11. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience. Grieser C; Steffen IG; Kramme IB; Bläker H; Kilic E; Perez Fernandez CM; Seehofer D; Schott E; Hamm B; Denecke T Eur Radiol; 2014 Jun; 24(6):1339-48. PubMed ID: 24658870 [TBL] [Abstract][Full Text] [Related]
12. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis. Kim TH; Woo S; Ebrahimzadeh S; McInnes MDF; Gerst SR; Do RK AJR Am J Roentgenol; 2023 Jan; 220(1):28-38. PubMed ID: 35920706 [No Abstract] [Full Text] [Related]
13. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma]. Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review. Guo Y; Li W; Cai W; Zhang Y; Fang Y; Hong G Int J Med Sci; 2017; 14(7):668-674. PubMed ID: 28824299 [No Abstract] [Full Text] [Related]
15. Gd-EOB-DTPA enhanced MRI nomogram model to differentiate hepatocellular carcinoma and focal nodular hyperplasia both showing iso- or hyperintensity in the hepatobiliary phase. Mao HY; Shen BQ; Zhang JY; Zhang T; Cai W; Fan YF; Wang XM; Yu YX; Hu CH BMC Med Imaging; 2024 Aug; 24(1):211. PubMed ID: 39134943 [TBL] [Abstract][Full Text] [Related]
16. Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI. Roux M; Pigneur F; Calderaro J; Baranes L; Chiaradia M; Tselikas L; Decaens T; Costentin C; Laurent A; Azoulay D; Mallat A; Zafrani ES; Rahmouni A; Luciani A J Magn Reson Imaging; 2015 Nov; 42(5):1249-58. PubMed ID: 25851028 [TBL] [Abstract][Full Text] [Related]
17. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio. Lebert P; Adens-Fauquembergue M; Azahaf M; Gnemmi V; Behal H; Luciani A; Ernst O Eur Radiol; 2019 Nov; 29(11):5742-5751. PubMed ID: 30993437 [TBL] [Abstract][Full Text] [Related]
18. Quantification of liver fat content in liver and primary liver lesions using triple-echo-gradient-echo MRI. Nougaret S; Monsonis B; Molinari N; Riviere B; Piron L; Kassam Z; Cassinotto C; Guiu B Eur Radiol; 2020 Sep; 30(9):4752-4761. PubMed ID: 32318848 [TBL] [Abstract][Full Text] [Related]
19. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study. Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905 [TBL] [Abstract][Full Text] [Related]
20. A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma. Suh CH; Kim KW; Park SH; Shin S; Ahn J; Pyo J; Shinagare AB; Krajewski KM; Ramaiya NH Eur Radiol; 2018 Jan; 28(1):214-225. PubMed ID: 28726119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]